Marker Therapeutics completes safety lead-in portion of mid-stage leukemia study
July 06 2021 - 7:50AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Marker Therapeutics (NASDAQ:MRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marker Therapeutics (NASDAQ:MRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024